Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identifying Novel Therapeutic Targets by Combining Transcriptional Data with Ordinal Clinical Measurements

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE98740 | GEO | 2017/05/11

SECONDARY ACCESSION(S): PRJNA386152

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements.

Project description: Not available

| S-EPMC5606996 | biostudies-literature

RNA-seq dataset for Identifying Novel Therapeutic Targets by Combining Transcriptional Data with Ordinal Clinical Measurements

Project description:The widespread adoption of transcriptional profiling has led to immense repositories of data that may contain critical insights for developing new therapies. Current approaches to mining these data largely rely on binary classifications of disease versus control. These methods are not able to incorporate measures of disease severity, which are often available. We report an analytical approach to integrate ordinal clinical information with transcriptomics. We have applied this method to public data for a large cohort of Huntington’s disease patients and controls, identifying and prioritizing phenotype-associated genes. To validate the approach, we have performed viability, siRNA knockdown, mRNA-seq, and ChIP-seq on striatal precursor cells expressing either full-length wild type (STHdh Q7) or mutant huntingtin (STHdh Q111). We have verified the role of a high-ranked gene in dysregulation of sphingolipid metabolism in the disease and demonstrated that inhibiting the enzyme, SPL, has neuroprotective effects in HD models. We have shown that one consequence of inhibiting SPL is the intracellular inhibition of HDACs, thus linking our observations in sphingolipid metabolism to a well-characterized HD pathway. Our approach is easily applied to any data with ordinal clinical measurements, and may deepen our understanding of disease processes.

2017-05-11 | GSE98739 | GEO

ChIP-seq dataset for H3K9ac in Identifying Novel Therapeutic Targets by Combining Transcriptional Data with Ordinal Clinical Measurements

2017-05-11 | GSE98738 | GEO

Identifying Novel Therapeutic Targets by Combining Transcriptional Data with Ordinal Clinical Measurements

Project description:Identifying Novel Therapeutic Targets by Combining Transcriptional Data with Ordinal Clinical Measurements

| PRJNA386152 | ENA

Perivascular adipose tissue as a regulator of vascular disease pathogenesis: identifying novel therapeutic targets.

Project description: Not available

| S-EPMC5610156 | biostudies-literature

Identifying unexpected therapeutic targets via chemical-protein interactome.

Project description: Not available

| S-EPMC2833192 | biostudies-literature